GlassScriptPhysician profile
Anne C Mailhot
NPI 1205385309
$7,059.65
in general payments reported to CMS, 2019-2025
6 companies · $5,733 in 2025
The $5,733 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $737 · 2024: $589 · 2025: $5,733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,125 · Travel and Lodging: $1,627 · Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,125.00 |
| Travel and Lodging | $1,626.80 |
| Food and Beverage | $570.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $6,063.07 | 2024-2025 | Ogsiveo |
| Deciphera Pharmaceuticals INC. | $600.00 | 2021 | |
| Revance Therapeutics, INC. | $156.46 | 2024 | Daxxify |
| Astrazeneca Pharmaceuticals LP | $124.76 | 2021 | |
| Galderma Laboratories, L.P. | $102.87 | 2024 | |
| Amgen INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Mailhot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.